2501 - 2550 of 8801 Results
Title
Year
- Mechanism of PINK1 activation by autophosphorylation and insights into assembly on the TOM complex2021OPENTitle: Mechanism of PINK1 activation by autophosphorylation and insights into assembly on the TOM complexJournal Name: Molecular CellPublisher: Elsevier BVVol: 82Issue #: 1Start Page: 44End Page: 59.e6Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.molcel.2021.11.012Best OA location URL: http://www.cell.com/article/S1097276521009916/pdfCitation Count: 85
-
OPENTitle: Detect and correct bias in multi-site neuroimaging datasetsJournal Name: Medical Image AnalysisPublisher: Elsevier BVVol: 67Issue #:Start Page: 101879End Page: 101879Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.media.2020.101879Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S1361841520302437?via%3DihubCitation Count: 99
-
RESTRICTEDTitle: Structure-constrained combination-based nonlinear association analysis between incomplete multimodal imaging and genetic data for biomarker detection of neurodegenerative diseasesJournal Name: Medical Image AnalysisPublisher: Elsevier BVVol: 78Issue #:Start Page: 102419End Page: 102419Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.media.2022.102419Citation Count: 11
-
RESTRICTEDTitle: Author response to comment on “The association between pain and impulse control behaviours in Parkinson's disease”Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 83Issue #:Start Page: 128End Page: 129Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.011Citation Count: 0
-
OPENTitle: Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI databaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 34End Page: 37Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.007Best OA location URL: https://repositorio.uca.edu.ar/handle/123456789/11625Citation Count: 12
-
OPENTitle: Exploratory analysis of the genetics of impulse control disorders in Parkinson's disease using genetic risk scoresJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 74End Page: 77Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.003Best OA location URL: https://hal.archives-ouvertes.fr/hal-03298502Citation Count: 8
-
RESTRICTEDTitle: Consistent skin α-synuclein positivity in REM sleep behavior disorder – A two center two-to-four-year follow-up studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 108End Page: 113Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.007Best OA location URL: http://hdl.handle.net/11380/1251595Citation Count: 24
-
OPENTitle: White matter hyperintensities mediate the impact of amyloid ß on future freezing of gait in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 85Issue #:Start Page: 95End Page: 101Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.02.031Citation Count: 14
-
OPENTitle: Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patientsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 87Issue #:Start Page: 25End Page: 31Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.012Best OA location URL: http://www.prd-journal.com/article/S1353802021001450/pdfCitation Count: 19
-
OPENTitle: Plasma NfL, clinical subtypes and motor progression in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 87Issue #:Start Page: 41End Page: 47Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.016Citation Count: 45
- Clinical-Instrumental patterns of neurodegeneration in Essential Tremor: A data-driven approach2021RESTRICTEDTitle: Clinical-Instrumental patterns of neurodegeneration in Essential Tremor: A data-driven approachJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 87Issue #:Start Page: 124End Page: 129Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.05.011Citation Count: 19
-
RESTRICTEDTitle: Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approachJournal Name: NeuropeptidesPublisher: Elsevier BVVol: 96Issue #:Start Page: 102283End Page: 102283Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.npep.2022.102283Citation Count: 9
-
RESTRICTEDTitle: Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 186Issue #:Start Page: 108465End Page: 108465Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108465Citation Count: 17
-
OPENTitle: Association ofGBAMutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 73Issue #: 10Start Page: 1217End Page: 1217Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2016.2245Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2546252/noi160057.pdfCitation Count: 213
-
OPENTitle: Combining clinical and biofluid markers for early Parkinson's disease detectionJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 5Issue #: 1Start Page: 109End Page: 114Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.509Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.509Citation Count: 10
-
OPENTitle: How firms undertake organizational changes to shift to more-exploratory strategies: A process perspectiveJournal Name: Research PolicyPublisher: Elsevier BVVol: 50Issue #: 1Start Page: 104118End Page: 104118Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.respol.2020.104118Best OA location URL: https://minesparis-psl.hal.science/hal-02943926Citation Count: 22
-
RESTRICTEDTitle: Optimal Treatment of Depression and Anxiety in Parkinson's DiseaseJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 29Issue #: 6Start Page: 530End Page: 540Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2021.02.037Citation Count: 53
-
RESTRICTEDTitle: The Importance of Cross-Disciplinary Research: A Commentary on “Brainstem Pathologies Correlate With Depression and Psychosis in Parkinson's Disease”Journal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 29Issue #: 9Start Page: 969End Page: 971Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2021.01.010Citation Count: 0
-
OPENTitle: Mitochondrial hyperfusion via metabolic sensing of regulatory amino acidsJournal Name: Cell ReportsPublisher: Elsevier BVVol: 40Issue #: 7Start Page: 111198End Page: 111198Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2022.111198Best OA location URL: http://www.cell.com/article/S2211124722010154/pdfCitation Count: 28
-
OPENTitle: Soluble P‐tau217 reflects both amyloid and tau pathology in the human brain and mediates the association of amyloid with neocortical tauJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: S5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.050391Citation Count: 0
-
RESTRICTEDTitle: Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease—ReplyJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 327Issue #: 1Start Page: 85End Page: 85Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jama.2021.21011Citation Count: 3
-
RESTRICTEDTitle: Effect of Urate-Elevating Inosine on Progression of Early Parkinson DiseaseJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 327Issue #: 1Start Page: 85End Page: 85Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jama.2021.21008Citation Count: 2
-
OPENTitle: Machine Learning for Predicting Rare Clinical Outcomes—Finding Needles in a HaystackJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 4Issue #: 5Start Page: e2110738End Page: e2110738Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2021.10738Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2780278/wang_2021_ic_210094_1620949822.15523.pdfCitation Count: 17
-
RESTRICTEDTitle: Ischemic Events After Intracerebral HemorrhageJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 7Start Page: 795End Page: 795Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.0772Citation Count: 3
- Citius, Fortius, Altius—Understanding Which Components Drive Exercise Benefits in Parkinson Disease2021OPENTitle: Citius, Fortius, Altius—Understanding Which Components Drive Exercise Benefits in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 12Start Page: 1443End Page: 1443Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.3744Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2785852/jamaneurology_de_vries_2021_ed_210020_1638811688.29228.pdfCitation Count: 14
- Reforming the Process for Deep Brain Stimulation and Neurologic Device Approval in Rare Diseases2020RESTRICTEDTitle: Reforming the Process for Deep Brain Stimulation and Neurologic Device Approval in Rare DiseasesJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 1Start Page: 5End Page: 5Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2020.4232Citation Count: 1
-
RESTRICTEDTitle: Bad Air and Parkinson Disease—The Fog May Be LiftingJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 7Start Page: 793End Page: 793Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.0863Citation Count: 7
-
RESTRICTEDTitle: Adjunctive Therapies in Parkinson Disease—Have We Made Meaningful Progress?Journal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 2Start Page: 119End Page: 119Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.4140Citation Count: 4
-
RESTRICTEDTitle: Timing of Physical Therapy Sessions for Individuals With Parkinson Disease May Unlock BenefitsJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 12Start Page: 1219End Page: 1219Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.2649Citation Count: 5
-
RESTRICTEDTitle: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease—ReplyJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 7Start Page: 726End Page: 726Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1604Citation Count: 0
-
RESTRICTEDTitle: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 7Start Page: 726End Page: 726Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1601Citation Count: 0
-
OPENTitle: Obesity, diabetes, and risk of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 12Start Page: 2253End Page: 2259Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23855Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3627531Citation Count: 160
-
OPENTitle: Treatment of myoclonus-dystonia syndrome with tetrabenazineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 12Start Page: 1423End Page: 1426Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.09.029Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4254189Citation Count: 34
-
OPENTitle: Adipose and leptomeningeal arteriole endothelial dysfunction induced by β-amyloid peptide: A practical human model to study Alzheimer's disease vasculopathyJournal Name: Journal of Neuroscience MethodsPublisher: Elsevier BVVol: 235Issue #:Start Page: 123End Page: 129Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jneumeth.2014.06.014Best OA location URL: http://doi.org/10.1016/j.jneumeth.2014.06.014Citation Count: 15
-
OPENTitle: Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patientsJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 80Issue #: 18Start Page: 1698End Page: 1701Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182904faaBest OA location URL: https://n.neurology.org/content/neurology/80/18/1698.full.pdfCitation Count: 197
-
OPENTitle: Multicenter Assessment of Immunohistochemical Methods for Pathological Alpha-Synuclein in Sigmoid Colon of Autopsied Parkinson’s Disease and Control SubjectsJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 6Issue #: 4Start Page: 761End Page: 770Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-160888Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5501392Citation Count: 88
-
OPENTitle: Epidemiology and neuropsychiatric manifestations of Young Onset Parkinson's Disease in the United StatesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 19Issue #: 2Start Page: 202End Page: 206Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.09.014Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3562561Citation Count: 46
-
OPENTitle: Amyloid-β Increases Tau by Mediating Sirtuin 3 in Alzheimer’s DiseaseJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 55Issue #: 11Start Page: 8592End Page: 8601Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s12035-018-0977-0Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6677544Citation Count: 70
-
OPENTitle: Subventricular zone neural progenitors from rapid brain autopsies of elderly subjects with and without neurodegenerative diseaseJournal Name: Journal of Comparative NeurologyPublisher: WileyVol: 515Issue #: 3Start Page: 269End Page: 294Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cne.22040Best OA location URL: http://doi.org/10.1002/cne.22040Citation Count: 55
-
OPENTitle: The human subthalamic nucleus and globus pallidus internus differentially encode reward during action controlJournal Name: Human Brain MappingPublisher: WileyVol: 38Issue #: 4Start Page: 1952End Page: 1964Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.23496Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.23496Citation Count: 29
-
OPENTitle: Phosphorylation of 4E-BP1 in the Mammalian Brain Is Not Altered by LRRK2 Expression or Pathogenic MutationsJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 7Issue #: 10Start Page: e47784End Page: e47784Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0047784Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0047784&type=printableCitation Count: 41
-
OPENTitle: 18F‐flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter studyJournal Name: Annals of NeurologyPublisher: WileyVol: 82Issue #: 4Start Page: 622End Page: 634Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.25060Best OA location URL: https://escholarship.org/uc/item/01j9450zCitation Count: 164
-
OPENTitle: Methylphenidate for gait impairment in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 14Start Page: 1256End Page: 1262Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182143537Best OA location URL: https://n.neurology.org/content/neurology/76/14/1256.full.pdfCitation Count: 91
-
OPENTitle: Behavioral and histopathological consequences of paraquat intoxication in mice: Effects of α‐synuclein over‐expressionJournal Name: SynapsePublisher: WileyVol: 61Issue #: 12Start Page: 991End Page: 1001Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/syn.20456Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3097512Citation Count: 183
-
OPENTitle: Deep brain stimulation induced normalization of the human functional connectome in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 142Issue #: 10Start Page: 3129End Page: 3143Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awz239Best OA location URL: https://academic.oup.com/brain/article-pdf/142/10/3129/30063714/awz239.pdfCitation Count: 155
-
OPENTitle: Clinical prediction of GBA carrier status in Parkinson’s diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 10Issue #:Start Page: 100251End Page: 100251Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100251Best OA location URL: https://doi.org/10.1016/j.prdoa.2024.100251Citation Count: 1
- Data‐driven disease progression model of Parkinson's disease and effect of sex and genetic variants2024OPENTitle: Data‐driven disease progression model of Parkinson's disease and effect of sex and genetic variantsJournal Name: CPT: Pharmacometrics & Systems PharmacologyPublisher: WileyVol: 13Issue #: 4Start Page: 649End Page: 659Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/psp4.13112Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/psp4.13112Citation Count: 8
-
OPENTitle: Assessing impulse control behaviors in early Parkinson’s disease: a longitudinal studyJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2023.1275170Best OA location URL: https://doi.org/10.3389/fneur.2023.1275170Citation Count: 3
-
OPENTitle: Baseline liver fibrosis-4 score correlates to the progression of anxiety and cognitive impairment in patients with Parkinson’s diseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 17Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2025.1501319Best OA location URL: https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2025.1501319/pdfCitation Count: 0
- Evidence for alpha-synuclein aggregation in older individuals with hyposmia: a cross-sectional study2025OPENTitle: Evidence for alpha-synuclein aggregation in older individuals with hyposmia: a cross-sectional studyJournal Name: eBioMedicinePublisher: Elsevier BVVol: 112Issue #:Start Page: 105567End Page: 105567Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2025.105567Best OA location URL: https://doi.org/10.1016/j.ebiom.2025.105567Citation Count: 2